SWTX: SpringWorks Therapeutics, Inc. Stock

by  •  • Comments Off on SWTX: SpringWorks Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3,314.68
Enterprise Value ($M) 3,196.64
Book Value ($M) 567.44
Book Value / Share 7.66
Price / Book 5.84
NCAV ($M) 382.41
NCAV / Share 5.17
Price / NCAV 8.67

Profitability (mra)
Return on Invested Capital (ROIC) -0.59
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio 6.77
Current Ratio 6.85

Balance Sheet (mrq) ($M)
Current Assets 471.80
Assets 656.83
Liabilities 89.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.45
Operating Income -343.01
Net Income -325.10

Cash Flow Statement (mra) ($M)
Cash From Operations -222.79
Cash from Investing 34.75
Cash from Financing 296.64

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Deep Track Capital, LP 5.53 24.88
02-14 13G/A EcoR1 Capital, LLC 0.00 -100.00
02-13 13G/A Vanguard Group Inc 8.38 39.66
02-09 13G/A Fmr Llc 15.00 15.48
01-26 13G/A BlackRock Inc. 7.50 61.88
01-23 13G/A State Street Corp 3.64 -30.25
12-06 13D/A Orbimed Advisors Llc 4.90 -14.63

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 132,487 552,522 23.98
2024-05-16 60,102 466,416 12.89
2024-05-15 185,129 604,089 30.65
2024-05-14 112,251 521,789 21.51
2024-05-13 73,443 572,228 12.83

(click for more detail)

Similar Companies
STOK – Stoke Therapeutics, Inc. STTK – Shattuck Labs, Inc.
SVRA – Savara Inc. SYRE – Spyre Therapeutics, Inc.
SYRS – Syros Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io